Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

NCT06798727 is registered in ClinicalTrials.gov with Medipost Co Ltd. as lead sponsor.

NCT NCT06798727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06798727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control
Lead sponsor
Medipost Co Ltd.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 20, 2023
Completion date
November 30, 2027
Enrollment
84 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis